文摘
The short half-life of current positron emission tomography (PET) cardiac tracers limits their widespread clinical use. We previously developed a 18F-labeled phosphonium cation, [18F]FPTP, that demonstrated sharply defined myocardial defects in a corresponding infarcted myocardium. The aim of this study was to compare the image properties of PET scans obtained using [18F]FPTP with those obtained using [13N]NH3 in rat myocardial infarction models. Perfusion abnormality was analyzed in 17 segments of polar map images. The myocardium-to-liver and myocardium-to-lung ratios of [18F]FPTP were 10.48 and 2.65 times higher, respectively, than those of [13N]NH3 in images acquired 30 min after tracer injection. The myocardial defect size measured by [18F]FPTP correlated more closely with the hypoperfused area measured by quantitative 2,3,5-triphenyltetrazolium chloride staining (r = 0.89, P < 0.01) than did [13N]NH3 (r = 0.84, P < 0.01). [18F]FPTP might be useful as a replacement for the myocardial agent [13N]NH3 in cardiac PET/CT applications.
Keywords:
Myocardial imaging agent; 18F-labeled phosphonium salt; [13N]ammonia; positron emission tomography (PET); myocardial infarction